SOPHARMA AD - Notification for merger of Achieve Lifesciences and Oncogenex

POLISH FINANCIAL SUPERVISION AUTHORITY

UNI - EN REPORT No 44 / 2017

Date of issue: 2017-06-15

Short name of the issuer

SOPHARMA AD

Subject

Notification for merger of Achieve Lifesciences and Oncogenex

Official market - legal basis

art. 17. 1 MAR.

Unofficial market - legal basis

Contents of the report:

We are pleased to announce that the next step in the process of merging Achieve Lifesciences and Oncogenex has been completed with the approval of the merger by the US SEC. OncoGenex will hold a special shareholder meeting on 1 August 2017 to vote the merger. Shortly after the newly formed entity will trade on NASDAQ stock exchange under the ticker symbol ACHV.

Annexes

File Description

3JR_notification Achieve.doc Notification for merger of Achieve Lifesciences and Oncogenex

SOPHARMA AD

(fullname of the issuer)

SOPHARMA AD Farmaceutyczny (far)

(short name of the issuer) (sector according to clasification of the WSE in Warsow)

1220 Sofia

(post code) (city)

IlienskoShosse 16

(street) (number)

[phone] [phone]

(phone number) (fax)

(e-mail) (web site)

nd

(NIP) (REGON)

SIGNATURE OF PERSONS REPRESENTING THE COMPANY

Date Name Position / Function Signature

2017-06-15 Ognian Donev Executive director